I beg to disagree that realistically, nothing has changed. For one, instead of having to wonder if IMU is on the radar of BP, well, wonder no more. IMU is on the radar of BP.
Secondly, with the likes of Merck and Pfizer involved here, it also validates the reputation of IMU to all other big pharma. After all, no big pharma will want to risk their reputation by being involved with a fly by night operation. This collaboration validates IMU's management quality. After all, without great management, there can be no great company. This collaboration will also make it easier for future collaboration with other big pharma. One will lead to two and two will lead to three and so on.
I am sure there are more points to be made, but I think I made my point.
- Forums
- ASX - By Stock
- IMU
- Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-203
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.6¢ | $1.826M | 30.80M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4225 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 229563 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4225 | 0.060 |
3 | 48114 | 0.057 |
16 | 1796819 | 0.056 |
29 | 4590043 | 0.055 |
10 | 1780287 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 5681 | 3 |
0.054 | 129783 | 1 |
0.055 | 40175 | 3 |
0.058 | 66541 | 9 |
0.059 | 959109 | 7 |
Last trade - 15.59pm 15/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online